New Delhi, Feb. 25 -- Ahmedabad-based drugmaker Zydus Lifesciences plans to launch its semaglutide injection brands upon patent expiry of the drug in India. The drugmaker said it will launch the drug ... Read More
Mumbai, Feb. 24 -- India's pharmaceutical companies, having conquered generics, must now pursue partnerships, collaborations and licensing deals to drive innovation at scale, industry executives said ... Read More
Mumbai, Feb. 24 -- Eris Lifesciences has tied up with Hyderabad-based Natco Pharma to commercialise semaglutide, ahead of the blockbuster weight-loss drug's patent expiry. The partnership comes on th... Read More
Mumbai, Feb. 14 -- Biocon Ltd is close to completing the integration of its subsidiary Biocon Biologics Ltd (BBL) with itself, after making progress last quarter on buying back the minority stake, Bio... Read More
Mumbai, Feb. 12 -- Early-stage healthcare-focused venture capital firm W Health Ventures is looking for bolder bets with its second fund, building companies from the ground up in areas like oncology, ... Read More
New Delhi, Feb. 11 -- Contract drug manufacturer OneSource Specialty Pharma received approval for its generic version of Ozempic in Saudi Arabia, clearing the path for selling the type-2 diabetes and ... Read More
New Delhi, Feb. 10 -- Apollo Hospitals on Tuesday beat Street estimates in the quarter ended December, led by strong demand for specialty care and double-digit growth across businesses. The hospital c... Read More
New Delhi, Feb. 10 -- French drug innovator Servier is partnering with domestic players to develop, manufacture and export formulations for the global market, highlighting India's growing role in glob... Read More
New Delhi, Feb. 4 -- Emcure Pharmaceuticals is tapping influencers and celebrities on social media, in addition to raising awareness among doctors, for its semaglutide brand, Poviztra, as it seeks to ... Read More
MUMBAI, Feb. 3 -- India's push to become a global hub for drug development faces a basic constraint: the country does not have enough standardized, trial-ready hospitals and clinics to scale up to mee... Read More